Skip to main content
Premium Trial:

Request an Annual Quote

Millipore, Guava to Integrate Flow Cytometry Reagents, Instrumentation

NEW YORK (GenomeWeb News) - Millipore and Guava Technologies have agreed to integrate their flow cytometry instrumentation, reagents, and support capabilities in an effort to target cell biologists, the companies said today.
 
Under the terms of the partnership, Millipore will develop co-branded reagent kits for Guava's flow cytometers. Millipore also has exclusive rights to distribute and service Guava's non-clinical instrumentation within certain regions of North America, Europe, and Asia.
 
The companies said they also plan to “work together to develop a new generation of instrumentation with enhanced performance and functionality.”
 
The first co-branded products under the partnership will be released in July.
 
Guava specializes in micro-capillary flow cytometry systems, which require smaller sample volumes, generate less waste, have lower operating costs, and are easier to set up and run than traditional flow cytometry technology, according to the company.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.